News
-
-
-
PRESS RELEASE
NanoViricides to Present at the Pharma Partnering Summit 2025 in Boston Today, November 14th - NV-387 is Effective Against H3N2
NanoViricides, Inc. to present NV-387, a revolutionary broad-spectrum antiviral drug, at Pharma Partnering Summit 2025. NV-387 mimics virus features to combat viral infections effectively -
-
PRESS RELEASE
5E Advanced Materials Hosts Q1 Call; Highlights Federal Recognition of Boron, Customer Validation, and Progress Toward 2026 FID
5E Advanced Materials, Inc. announces key takeaways from fiscal first-quarter conference call, highlighting boron's U.S. Critical Mineral designation and progress towards Final Investment Decision (FID) in 2026 -
PRESS RELEASE
TRNR Reports Record Third Quarter 2025 Results with 139% YoY Growth; Reiterates 2025 Pro Forma Revenue Guidance of $80M+ To Be Driven by Completion of Sportstech Acquisition
Interactive Strength Inc. reports record quarterly revenue of $4.8M with net loss of $5.2M and $3.11 loss per diluted share in Q3 2025, due to low inventory availability and pending Sportstech acquisition -
-
PRESS RELEASE
Plaintree Systems Inc. Announces First Quarter Fiscal 2026 Results
Plaintree Systems Inc. releases unaudited financial statements for Q2 Fiscal 2026 with revenues of $4,691,162 and net income of $924,152 for the quarter ending September 30, 2025. Details on recertification progress and division operations -
PRESS RELEASE
Arrive AI Announces Third Quarter 2025 Results, Continued Momentum on Strategic and Operating Milestones
Arrive AI (NASDAQ: ARAI) reports Q3 2025 highlights, financial results, strategic partnerships, and product updates. CEO Dan O'Toole emphasizes growth plans and innovative technologies -
